TABLE 1.
Demographic characteristics of subjects
| Treatment effect | Tumor recurrence | P value | |
|---|---|---|---|
| Subject number (%) | 26 (30.2%) | 60 (69.8%) | |
| Age (mean ± SD; year) | 55.6 ± 13.1 | 50.7 ± 12.4 | 0.323 |
| Gender (n) Male |
14 | 39 | 0.345 |
| Female | 12 | 21 | |
| Time after (chemo)radiation completion (median, range; day) | 171, 28–1746 | 190, 18–3655 | 0.502 |
| WHO grade (n) III |
4 | 22 | 0.073 |
| IV | 22 | 38 | |
| Surgery (n) Gross total resection |
15 | 31 | 0.607 |
| Other surgical procedures | 11 | 29 | |
| 2nd line therapy (n) With |
7 | 16 | 0.980 |
| Without | 19 | 44 | |
| Pathological type (n) Glioblastoma |
21 | 36 | 0.073 |
| Anaplastic oligodendroglioma | 1 | 4 | |
| Anaplastic astrocytoma | 3 | 20 | |
| Other | 1 gliosarcoma | 0 | |
| Diagnostic standards (n) Integrated clinical diagnosis |
19 | 43 | 0.893 |
| Pathological report | 7 | 17 |
Independent t test, Pearson’s chi-squared test and Kruskal–Wallis test were applied for numerical data or categorical data separately.